0001144204-16-095369.txt : 20160420
0001144204-16-095369.hdr.sgml : 20160420
20160420180019
ACCESSION NUMBER: 0001144204-16-095369
CONFORMED SUBMISSION TYPE: 3/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20151231
FILED AS OF DATE: 20160420
DATE AS OF CHANGE: 20160420
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ReWalk Robotics Ltd.
CENTRAL INDEX KEY: 0001607962
STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842]
IRS NUMBER: 000000000
BUSINESS ADDRESS:
STREET 1: KOCHAV YOKNEAM BUILDING, FLOOR 6
STREET 2: P.O. BOX 161
CITY: YOKNEAM ILIT
STATE: L3
ZIP: 20692
BUSINESS PHONE: 97249590123
MAIL ADDRESS:
STREET 1: KOCHAV YOKNEAM BUILDING, FLOOR 6
STREET 2: P.O. BOX 161
CITY: YOKNEAM ILIT
STATE: L3
ZIP: 20692
FORMER COMPANY:
FORMER CONFORMED NAME: Argo Medical Technologies Ltd.
DATE OF NAME CHANGE: 20140513
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Disanzo Deborah
CENTRAL INDEX KEY: 0001661251
FILING VALUES:
FORM TYPE: 3/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36612
FILM NUMBER: 161582181
MAIL ADDRESS:
STREET 1: KOCHAV YOKNEAM BUILDING, FLOOR 6
STREET 2: P.O. BOX 161
CITY: YOKNEAM ILIT
STATE: L3
ZIP: 20692
3/A
1
v437120_3a.xml
OWNERSHIP DOCUMENT
X0206
3/A
2015-12-31
2015-12-31
0
0001607962
ReWalk Robotics Ltd.
RWLK
0001661251
Disanzo Deborah
C/O REWALK ROBOTICS LTD.
3 HATNUFA ST., P.O. BOX 161
YOKNEAM ILIT
L3
20692203
ISRAEL
1
0
0
0
Option (Right to buy)
7.3
2025-12-03
Ordinary Shares
4176
D
Option (Right to buy)
9.21
2025-09-16
Ordinary Shares
12546
D
Represents stock options granted under the ReWalk 2014 Equity Incentive Plan on December 3, 2015. The options become vested and exercisable in 12 equal quarterly installments starting three months following the date of grant.
The Reporting Person is amending the Form 3 filed on December 31, 2015 to clarify the terms of the vesting schedule of the stock options to purchase 4,176 Ordinary Shares reported therein.
Represents stock options granted under the ReWalk 2014 Equity Incentive Plan on September 16, 2015. The options become vested and exercisable in 12 equal quarterly installments starting three months following the date of grant.
The Reporting Person is amending the Form 3 filed on December 31, 2015 to clarify the terms of the vesting schedule of the stock options to purchase 12,546 Ordinary Shares reported therein.
The exercise price of the stock options represents the higher of the fair market value of the Issuer's Ordinary Shares as of August 17, 2015 (the date that the Issuer's board of directors approved the stock option grant in connection with its approval of the Reporting Person's appointment as a director of the Issuer) and the fair market value of the Issuer's Ordinary Shares as of September 16, 2015 (the effective date of the Reporting Person's appointment as a director of the Issuer).
/s/ Kevin Hershberger, as attorney-in-fact
2016-04-20